SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-08-002639
Filing Date
2008-05-09
Accepted
2008-05-09 17:02:20
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c73328e10vq.htm 10-Q 320609
2 EXHIBIT 31.1 c73328exv31w1.htm EX-31.1 8997
3 EXHIBIT 31.2 c73328exv31w2.htm EX-31.2 9224
4 EXHIBIT 32.1 c73328exv32w1.htm EX-32.1 3295
5 EXHIBIT 32.2 c73328exv32w2.htm EX-32.2 3269
  Complete submission text file 0001362310-08-002639.txt   346806
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 08819462
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1